Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting

被引:29
作者
Fengler, Sophie [1 ,2 ,3 ]
Kessler, Josef [4 ]
Timmermann, Lars [4 ]
Zapf, Alexandra [1 ]
Elben, Saskia [5 ]
Wojtecki, Lars [5 ]
Tucha, Oliver [6 ]
Kalbe, Elke [1 ,2 ,3 ]
机构
[1] Univ Hosp Cologne, Dept Med Psychol Neuropsychol & Gender Studies, Cologne, Germany
[2] Univ Vechta, Inst Gerontol, Vechta, Germany
[3] Univ Vechta, Ctr Neuropsychol Diagnost & Intervent CeNDI, Vechta, Germany
[4] Univ Hosp Cologne, Dept Neurol, Cologne, Germany
[5] Univ Hosp Dusseldorf, Ctr Movement Disorders & Neuromodulat, Dept Neurol, Dusseldorf, Germany
[6] Univ Groningen, Fac Behav & Social Sci, Dept Clin & Dev Neuropsychol, Groningen, Netherlands
关键词
MINI-MENTAL-STATE; QUALITY-OF-LIFE; EXECUTIVE DYSFUNCTION; VISUAL DYSFUNCTION; DEMENTIA; INSTRUMENTS; DEPRESSION; POPULATION; DISABILITY; DEFICITS;
D O I
10.1371/journal.pone.0159318
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Given the high prevalence of cognitive impairment in Parkinson's disease (PD), cognitive screening is important in clinical practice. The Montreal Cognitive Assessment (MoCA) is a frequently used screening test in PD to detect mild cognitive impairment (PD-MCI) and Parkinson's disease dementia (PD-D). However, the proportion in which the subtests are represented in the MoCA total score does not seem reasonable. We present the development and preliminary evaluation of an empirically based alternative scoring system of the MoCA which aims at increasing the overall diagnostic accuracy. Methods In study 1, the MoCA was administered to 40 patients with PD without cognitive impairment (PD-N), PD-MCI, or PD-D, as defined by a comprehensive neuropsychological test battery. The new MoCA scoring algorithm was developed by defining Areas under the Curve (AUC) for MoCA subtests in a Receiver Operating Characteristic (ROC) and by weighting the sub-tests according to their sensitivities and specificities. In study 2, an independent sample of 24 PD patients (PD-N, PD-MCI, or PD-D) was tested with the MoCA. In both studies, diagnostic accuracy of the original and the new scoring procedure was calculated. Results Diagnostic accuracy increased with the new MoCA scoring algorithm. In study 1, the sensitivity to detect cognitive impairment increased from 62.5% to 92%, while specificity decreased only slightly from 77.7% to 73%; in study 2, sensitivity increased from 68.8% to 81.3%, while specificity stayed stable at 75%. Conclusion This pilot study demonstrates that the sensitivity of the MoCA can be enhanced substantially by an empirically based weighting procedure and that the proposed scoring algorithm may serve the MoCA's actual purpose as a screening tool in the detection of cognitive dysfunction in PD patients better than the original scoring of the MoCA. Further research with larger sample sizes is necessary to establish efficacy of the alternate scoring system.
引用
收藏
页数:19
相关论文
共 58 条
[1]   The rate of cognitive decline in Parkinson disease [J].
Aarsland, D ;
Andersen, K ;
Larsen, JP ;
Perry, R ;
Wentzel-Larsen, T ;
Lolk, A ;
Kragh-Sorensen, P .
ARCHIVES OF NEUROLOGY, 2004, 61 (12) :1906-1911
[2]   Cognitive impairment in incident, untreated Parkinson disease The Norwegian ParkWest Study [J].
Aarsland, D. ;
Bronnick, K. ;
Larsen, J. P. ;
Tysnes, O. B. ;
Alves, G. .
NEUROLOGY, 2009, 72 (13) :1121-1126
[3]   The epidemiology of dementia associated with Parkinson disease [J].
Aarsland, Dag ;
Kurz, Martin Wilhelm .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 289 (1-2) :18-22
[4]   Attention and visual dysfunction in Parkinson's disease [J].
Botha, Hugo ;
Carr, Jonathan .
PARKINSONISM & RELATED DISORDERS, 2012, 18 (06) :742-747
[5]   Dementia and survival in Parkinson disease - A 12-year population study [J].
Buter, T. C. ;
van den Hout, A. ;
Matthews, F. E. ;
Larsen, J. P. ;
Brayne, C. ;
Aarsland, D. .
NEUROLOGY, 2008, 70 (13) :1017-1022
[6]   Defining mild cognitive impairment in Parkinson's disease [J].
Caviness, John N. ;
Driver-Dunckley, Erika ;
Connor, Donald J. ;
Sabbagh, Marwan N. ;
Hentz, Joseph G. ;
Noble, Brie ;
Evidente, Virgilio Gerald H. ;
Shill, Holly A. ;
Adler, Charles H. .
MOVEMENT DISORDERS, 2007, 22 (09) :1272-1277
[7]  
Cecato JF, 2015, INT PSYCHOGERIATR, V1, P1
[8]   A Recommended Scale for Cognitive Screening in Clinical Trials of Parkinson's Disease [J].
Chou, Kelvin L. ;
Amick, Melissa M. ;
Brandt, Jason ;
Camicioli, Richard ;
Frei, Karen ;
Gitelman, Darren ;
Goldman, Jennifer ;
Growdon, John ;
Hurtig, Howard I. ;
Levin, Bonnie ;
Litvan, Irene ;
Marsh, Laura ;
Simuni, Tanya ;
Troester, Alexander I. ;
Uc, Ergun Y. .
MOVEMENT DISORDERS, 2010, 25 (15) :2501-2507
[9]   The MoCA Well-suited screen for cognitive impairment in Parkinson disease [J].
Dalrymple-Alford, J. C. ;
MacAskill, M. R. ;
Nakas, C. T. ;
Livingston, L. ;
Graham, C. ;
Crucian, G. P. ;
Melzer, T. R. ;
Kirwan, J. ;
Keenan, R. ;
Wells, S. ;
Porter, R. J. ;
Watts, R. ;
Anderson, T. J. .
NEUROLOGY, 2010, 75 (19) :1717-1725
[10]   The Montreal Cognitive Assessment and the Mini-Mental State Examination as Screening Instruments for Cognitive Impairment: Item Analyses and Threshold Scores [J].
Damian, Anne M. ;
Jacobson, Sandra A. ;
Hentz, Joseph G. ;
Belden, Christine M. ;
Shill, Holly A. ;
Sabbagh, Marwan N. ;
Caviness, John N. ;
Adler, Charles H. .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2011, 31 (02) :126-131